Skip to main content
. 2021 May 12;11(5):402. doi: 10.3390/jpm11050402

Table 3.

Available Treatments for Patients with Breast Cancer-Related Lymphedema.

Treatment Indication Advantages Disadvantages
Complex Decongestive Therapy
  • CLG 0-I

  • Reduction lymphedema volume, pain and arm heaviness

  • Improvement lymphatic function

  • Acceptable quality of life

  • Reduction episodes of cellulitis

  • It is a purely symptomatic treatment

  • Needs patient compliance

  • Life-long compression garments.

Lymphovenous anastomosis
  • CLG I- early II

  • Safe

  • Reduces of Circumference

  • Reduces callulitis

  • Technically difficult

  • Needs supermicrosurgery instruments

  • Needs high resolution microscope

  • Needs ICG lymphography

  • Difficult to monitor the anastomoses patency

Vascularized Lymph Node Transfer
  • CLG late II-III-IV

  • Improvements in circumferential measurements, episodes of cellulitis, and quality of life

  • Requires intraoperative techniques of greater complexity

  • Higher risk for postoperative re-exploration and the flap inset

  • Risk of donor-site lymphedema

Liposuction
  • CLG III-IV

  • Decrease limb size

  • Reduces episodes of cellulitis

  • Improve quality of life

  • Risks of swelling recurrence

  • Life-long compression garments

CLG: Cheng’s Lymphedema Grading.